Boulevard Bio

Private

Cambridge-based biotech building AI-designed viral vector delivery systems for gene therapy.

Founders Michael Kim

CEO Michael Kim

Company

Founded

2023

Headquarters

Cambridge, United States

Financials

Total Funding

$49M

Sectors

Artificial Intelligence Biotech

boulevardbio.com

Funding History

2 rounds

Series A Aug 21, 2026

$38M

Flagship Pioneering (Lead) ARCH Venture Partners Third Rock Ventures

Seed May 15, 2024

$11M

Flagship Pioneering (Lead) ARCH Venture Partners

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.